Fiscal year ending 2023. Filed on November 14, 2024.
57 West 57th St 904
New York, New York 10019
Alzheimer's Drug Discovery Foundation (EIN: 20-1082179) has filed an IRS Form 990 since at least fiscal year 2016. In its fiscal year 2023 IRS Form 990 filing, Alzheimer's Drug Discovery Foundation, a 501(c)(3) charitable organization, reported compensation for 8 out of 47 total employees. Among the employees shown here, the average compensation is $418,384. The highest compensated employee at Alzheimer's Drug Discovery Foundation is Howard Fillit, M.D. with fiscal year 2023 compensation of $664,906.
Revenue
Expenses
Employee compensation
ACCELERATE THE DISCOVERY OF DRUGS TO PREVENT, TREAT AND CURE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS.
Be the first to know when new IRS Form 990 data is published for this organization.